110 related articles for article (PubMed ID: 15183193)
1. Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.
Atarod EB; Kehrer JP
Free Radic Biol Med; 2004 Jul; 37(1):36-47. PubMed ID: 15183193
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.
Soller M; Dröse S; Brandt U; Brüne B; von Knethen A
Mol Pharmacol; 2007 Jun; 71(6):1535-44. PubMed ID: 17325128
[TBL] [Abstract][Full Text] [Related]
3. Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha.
Qu C; Leung SW; Vanhoutte PM; Man RY
Eur J Pharmacol; 2012 Dec; 696(1-3):101-10. PubMed ID: 23022336
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.
Strakova N; Ehrmann J; Bartos J; Malikova J; Dolezel J; Kolar Z
Neoplasma; 2005; 52(2):126-36. PubMed ID: 15800711
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor-gamma (PPARgamma) induces cell death through MAPK-dependent mechanism in osteoblastic cells.
Kim SH; Yoo CI; Kim HT; Park JY; Kwon CH; Kim YK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):198-207. PubMed ID: 16616945
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of peroxisome proliferator-activated receptor alpha and gamma agonists in renal proximal tubular cell lines.
Giral H; Villa-Bellosta R; Catalán J; Sorribas V
Toxicol In Vitro; 2007 Sep; 21(6):1066-76. PubMed ID: 17521863
[TBL] [Abstract][Full Text] [Related]
9. Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels.
Chopra B; Georgopoulos NT; Nicholl A; Hinley J; Oleksiewicz MB; Southgate J
Cell Prolif; 2009 Oct; 42(5):688-700. PubMed ID: 19614673
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.
Yang C; Jo SH; Csernus B; Hyjek E; Liu Y; Chadburn A; Wang YL
Am J Pathol; 2007 Feb; 170(2):722-32. PubMed ID: 17255338
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
[TBL] [Abstract][Full Text] [Related]
12. Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion.
Thuillier P; Anchiraico GJ; Nickel KP; Maldve RE; Gimenez-Conti I; Muga SJ; Liu KL; Fischer SM; Belury MA
Mol Carcinog; 2000 Nov; 29(3):134-42. PubMed ID: 11108658
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism.
Sharifpanah F; Wartenberg M; Hannig M; Piper HM; Sauer H
Stem Cells; 2008 Jan; 26(1):64-71. PubMed ID: 17951219
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.
Knight B; Yeap BB; Yeoh GC; Olynyk JK
Carcinogenesis; 2005 Oct; 26(10):1782-92. PubMed ID: 15917308
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
16. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
[TBL] [Abstract][Full Text] [Related]
17. PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells.
Lachal S; Ford J; Shulkes A; Baldwin GS
Regul Pept; 2004 Aug; 120(1-3):243-51. PubMed ID: 15177943
[TBL] [Abstract][Full Text] [Related]
18. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of PPARα normalizes the skin lipid ratio and improves the skin barrier of normal and filaggrin deficient reconstructed skin.
Wallmeyer L; Lehnen D; Eger N; Sochorová M; Opálka L; Kováčik A; Vávrová K; Hedtrich S
J Dermatol Sci; 2015 Nov; 80(2):102-10. PubMed ID: 26472199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
